Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Test for early detection of BSE, vCJD on horizon?

Claudia Orellana
CMAJ July 24, 2001 165 (2) 199-199-b;
Claudia Orellana
Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

A new method for detecting abnormal prion proteins is being developed by a research team in Switzerland. The technique, protein misfolding cyclic amplification, could lead to a test for the early diagnosis of bovine spongiform encephalopathy (BSE) or new variant Creutzfeldt–Jakob (vCJD) disease long before any symptoms are visible. Existing tests for BSE are capable only of detecting the disease in cattle after death.

The replication of prion proteins associated with neurodegenerative diseases can take up to 40 years in vivo, but a team led by Dr. Claudio Soto of the Serono Pharmaceutical Research Institute in Geneva has been able to complete the process in a single day. “When an animal or a human being gets infected with the prion, this abnormal protein begins to replicate very slowly and transforms the host's normal protein into abnormal protein,” says Soto. “So we thought, why can't we do the same thing in a test tube?”

The abnormal protein grows to form aggregates that remain clumped together for long periods. “The rate of growth depends on the number of units,” says Soto. “So we tried letting them grow and then breaking them into little pieces, incubating them again to let them grow, and so on in a cyclical process.”

The method is analogous to polymerase chain reaction (PCR), the cyclical technique commonly used to detect DNA by amplification. “You can't use conventional PCR here, because there is no DNA,” he added. “We tried to create an amplification system like a PCR, but specially for proteins.” Minute quantities of hamster brain tissue infected with scrapie were mixed with normal protein from the brain tissue of healthy hamsters, and ultrasound was used to break apart the prion aggregates (Nature 411:810-3). Detection of the resulting abnormal protein was performed by densitometric analysis.

The slow rate of replication has hampered investigation into the structural and infectious properties of abnormal prion proteins. Accelerating the conversion process will allow for in-vitro research aimed at understanding the molecular mechanisms of prion replication. Meanwhile, evidence of blood infectiveness remains circumstantial. Animals injected with large quantities of blood from infected animals have gone on to develop prion diseases, but Soto says there is no assurance that the prion is really present in blood “because none of the methods so far has been able to detect it there. Now, for the first time, we have the chance to examine if it really is there. We have some preliminary results in animals, which are positive. We also have blood from patients with CJD and nvCJD and we will be able to test this very quickly.”

Although other neurodegenerative illnesses such as Alzheimer's and Parkinson's disease are not thought to be infectious, they share characteristics with prion diseases. “All these diseases are caused by changes in the shape of a normal protein, which then tends to aggregate, forming deposits in the brain,” says Soto. “[This leads to] the death of neurons and brain damage. The molecular mechanisms are similar, so we believe this method could be applied to diagnose these diseases as well.”

PreviousNext
Back to top

In this issue

CMAJ
Vol. 165, Issue 2
24 Jul 2001
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Test for early detection of BSE, vCJD on horizon?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Test for early detection of BSE, vCJD on horizon?
Claudia Orellana
CMAJ Jul 2001, 165 (2) 199-199-b;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Test for early detection of BSE, vCJD on horizon?
Claudia Orellana
CMAJ Jul 2001, 165 (2) 199-199-b;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feds update immunization advice with Moderna vaccine approval
  • Canada will have three-digit suicide prevention hotline by 2023
  • Trudeau promises to boost federal health transfers when the pandemic is over
Show more News

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire